| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 5508-58-7 | 穿心蓮內(nèi)酯 | Andrographolide; Andrographolide |  | C20H30O5 | 詳情 | 供應(yīng)商 |
| 28371-51-9 | Grayanotoxan-6-one,10,20-didehydro-3,5,14,16-tetrahydroxy-, (3b,14R)- (9CI); 7,9a-Methano-9aH-cyclopenta[b]heptalen-11(10H)-one,dodecahydro-2,8,11a,12-tetrahydroxy-1,1,8-trimethyl-4-methylene-,(2S,3aS,4aS,7R,8R,9aR,11aR,12R)- (8CI); 7,9a-Methano-9aH-cyclopenta[b]heptalene, grayanotoxan-6-one deriv.; 6-Dehydrograyanotoxin II |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 113105-71-8 | Kaur-16-en-15-one,3,7,14,20-tetrahydroxy-, (3b,7a,14R)- (9CI); 1H-2,10a-Ethanophenanthrene,kaur-16-en-15-one deriv.; (-)-Coestinol; Coestinol; Coetsoidin B |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 123941-76-4 | Kaur-16-en-15-one,1,2,7,14-tetrahydroxy-, (1a,2b,7a,14R)- (9CI); 1H-2,10a-Ethanophenanthrene,kaur-16-en-15-one deriv.; (-)-Umbrosianin; Umbrosianin |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 126005-68-3 | Kaur-16-en-15-one,7,11,14,18-tetrahydroxy-, (4b,7a,11b,14R)-; (-)-RabdokunminD; Rabdokunmin D |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 126005-67-2 | Kaur-16-en-15-one,7,12,14,18-tetrahydroxy-, (4b,7a,12a,14R)-; (-)-RabdokunminC; Rabdokunmin C |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 125456-65-7 | Kaur-16-en-15-one,7,11,12,14-tetrahydroxy-, (7a,11b,12a,14R)-; RabdoloxinB |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 125456-64-6 | Kaur-16-en-15-one,1,7,11,14-tetrahydroxy-, (1a,7a,11b,14R)-; (-)-RabdoinflexinB; Rabdoinflexin B |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 141358-58-9 | Kaur-16-en-15-one,3,7,14,18-tetrahydroxy-, (3a,4b,7a,14R)- (9CI); 1H-2,10a-Ethanophenanthrene,kaur-16-en-15-one deriv.; (-)-Parvifolin A; Parvifolin A |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 73981-34-7 | Kaur-16-en-15-one,1,7,14,20-tetrahydroxy-, (1a,7a,14R)-; 1a,7a,14b,20-Tetrahydroxy-ent-kaur-16-en-15-one; Kamebakaurin |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 220832-60-0 | Kaur-16-ene-1,7,11,15-tetrol,7,20-epoxy-, (1a,7a,11b,15b)- (9CI); MegathyrinB |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 105426-69-5 | Kaur-16-en-15-one,1,7,14,20-tetrahydroxy-, (1b,7a,14R)- (9CI); 1H-2,10a-Ethanophenanthrene,kaur-16-en-15-one deriv.; Rabdoserrin D |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 130217-26-4 | Kauran-18-oic acid,11,16-epoxy-15,17-dihydroxy-, (4a,11b,15b,16a)- (9CI); 3H-1,4:3,5a-Dimethanonaphth[1,2-c]oxepin,kauran-18-oic acid deriv.; (-)-Adenostemmoic acid G; Adenostemmoic acid G |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 23807-59-2 | Kaur-16-ene-1,6,7,15-tetrol,7,20-epoxy-, (1b,6b,7a,15b)- (9CI); Kaur-16-ene-1b,6b,7b,15b-tetrol, 7,20-epoxy- (8CI); Enmelol |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 78536-37-5 | Kaur-16-en-15-one,1,7,12,14-tetrahydroxy-, (1a,7a,12a,14R)-; 1H-2,10a-Ethanophenanthrene,kaur-16-en-15-one deriv.; 1a,7a,12a,14b-Tetrahydroxy-ent-kaur-16-en-15-one; Excisanin A |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 130396-69-9 | Kaur-16-en-15-one,3,7,12,14-tetrahydroxy-, (3a,7a,12a,14S)-; PseurataB |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 125494-67-9 | Kaur-16-en-15-one,7,11,12,14-tetrahydroxy-, (7a,11a,12b,14R)- (9CI); 1H-2,10a-Ethanophenanthrene,kaur-16-en-15-one deriv.; Loxorabdosin B |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 71902-47-1 | Prosta-5,13,17-trien-1-oicacid, 9,15-dihydroxy-11-oxo-, (5Z,9a,13E,15S,17Z)-; PGD3; Prostaglandin D3 |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 74853-73-9 | Prost-5-en-13-yn-1-oicacid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9a,11a,15S)- (9CI); 2H-Cyclopenta[b]furan,prost-5-en-13-yn-1-oic acid deriv. |  | C20H30O5 | 詳情 | 供應(yīng)商 | |
| 100311-07-7 | Prosta-5,13-dien-1-oicacid, 6,9-epoxy-11-hydroxy-15-oxo-, (5Z,9a,11a,13E)- (9CI); 2H-Cyclopenta[b]furan,prosta-5,13-dien-1-oic acid deriv. |  | C20H30O5 | 詳情 | 供應(yīng)商 | |